Anita Wagner

Anita Katharina Wagner, PharmD, MPH, DrPH

Fellow in Bioethics

Anita Katharina Wagner is Associate Professor in the Division of Health Policy and Insurance Research at the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She also serves as the Director of the Harvard Pilgrim Health Care Ethics Program

Dr. Wagner conducts empirical research generating evidence for answering challenging health system questions.  Her work, frequently in large databases, evaluates impacts of insurance and other policy changes on the availability, access to, affordability, and use of medicines, specifically new cancer medicines, in the United States, China, and elsewhere.    

Through the Medicines and Insurance Coverage (MedIC) Initiative she founded, Dr. Wagner has led training programs, including the first online course, to strengthen capacity of professionals in more than 20 low and middle income country health systems to design, implement, monitor and evaluate medicines policies and programs in the context of expanding health insurance coverage.

Dr. Wagner co-directs the Harvard Medical School Fellowship in Health Policy and Insurance Research and the Department of Population Medicine Center for Cancer Policy and Program Evaluation (CarPE)

Serving as a pharmacoepidemiologist on the FDA’s Sentinel Initiative, Dr. Wagner contributes to a national system that tracks the safety of pharmaceuticals in the United States. 

Dr. Wagner holds a German master-equivalent degree in pharmacy, a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences, a Master of Public Health degree in international health and a Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She completed training programs in bioethics including the Harvard Medical School Fellowship in Bioethics.

Publications View
Health-related quality of life issues
Authors: Authors: Wagner AK, Shea CC, Sant G
Interstitial Cystitis
A descriptive review of the methodologies used in household surveys on medicine utilization
Authors: Authors: Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC
BMC Health Serv Res
Classification of donated drugs
Authors: Authors: Wagner AK, Massaro FJ
An assessment of U.S
Medicine access and utilization in a population covered by primary health care in Brazil
Authors: Authors: Bertoldi AD, Barros AJ, Wagner A, Ross-Degnan D, Hallal PC
Health Policy
Redefining the affordability of medication expenditures among Medicaid enrollees
Authors: Authors: Briesacher BA, Ross-Degnan D, Adams AS, Wagner AK, Gurwitz J, Soumerai SB
J Health and Soc Policy Review (in press)
Medicine Coverage and Community-Based Health Insurance in Low-Income Countries
Authors: Authors: Vialle-Valentin C, Ross-Degnan D, Wagner AK
Health Res Policy Syst
The social determinants of health working group report
Authors: Authors: Wagner AK
Robert Wood Johnson Foundation Investigator Awards in Health Policy Program
Decisions about medication use by adults with respiratory infections in Bangkok slum communities: Implications for interventions to reduce antimicrobial resistance
Authors: Authors: Suttajit S, Tantipidoke R, Wagner AK, Ross-Degnan D, Sitthi-amorn C
Submitted
The potential for insurance systems to increase access to and appropriate use of medicines in Asia-Pacific countries
Authors: Authors: Wagner AK, Ross-Degnan D
Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific
Methods for estimating confidence intervals in interrupted time series analyses of health interventions
Authors: Authors: Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D
Journal of Clinical Epidemiology

Address: 
Harvard Pilgrim Health Care Institute
Landmark Center
401 Park Dr
Boston, MA 02215